Gary Lyman, MD, MPH, senior lead for quality and policy at the Hutchinson Institute for Cancer Outcomes Research, explains that it may take 8-12 years to prove that biosimilars should be trusted in everyday clinical practice, as well as delves into issues of granting extrapolation. Dr Nabhan and Dr Lyman have no relevant financial disclosures.
Dr. Sanjay Patel of Weill Cornell and Dr. Greg Goldgof of Memorial Sloan Kettering dive into the transformative role of AI in modern pathology. They…
Yelak Biru, President and CEO of the International Myeloma Foundation (IMF), joins the show to share his remarkable personal and professional journey. After imm
The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention (A Johns Hopkins Press Health Book)
David Canes, CEO of WellPrept and a Boston-based urologist, joins the Healthcare Unfiltered show to share the story behind his innovative platform designed t…
The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention (A Johns Hopkins Press Health Book)
The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention (A Johns Hopkins Press Health Book)
David Canes, CEO of WellPrept and a Boston-based urologist, joins the show to share the story behind his innovative platform designed to reduce physician burnou
Graduating fellows Jennifer Marks and Megan Melody join the show to discuss the challenges of navigating the job search during fellowship. They share insights o
In Western countries, the current standard of care for resectable gastric cancer is perioperative chemotherapy. Preoperative chemoradiotherapy has been considered, but data are limited regarding…
Yelak Biru, President and CEO of the International Myeloma Foundation (IMF), joins the show to share his remarkable personal and professional journey. After imm
